Treatment responses with once-weekly teriparatide therapy for osteoporosis
Crossref DOI link: https://doi.org/10.1007/s00198-016-3640-5
Published Online: 2016-05-27
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shiraki, M.
Ueda, S.
Sugimoto, T.
Kuroda, T.
Nakamura, T.
Funding for this research was provided by:
Asahi Kasei Pharma Corporation
License valid from 2016-05-27